2025永久免费梯子

Our Company
- Our Company Overview
- Our Leadership
- Our Community
- Compliance & Transparency
What We Do
- What We Do Overview
- Discovery & Development
- Partnerships
- Portfolio
- Therapies & Support
For Investors
- Investors Overview
- Events & Presentations
- Financial Information
- Stock Information
- Corporate Governance
- Investor Q&A
- Investor Contacts
Responsibility
- Patients
- Team
- 狸猫网络加速器免费
- Community
- Sustainable Business Practices
Incyte News
- Incyte News Overview
- Company Statements
- Email Alerts
- RSS Feeds
- Media Contacts
Join our Team
- Join Our Team Overview
- 狸猫网络加速器免费
Incyte Involved
Contact Us
- Contact Us Overview
- Our Locations
- Medical Information

2025永久免费梯子

For Investors

Incyte International Locations

NORTH AMERICA—
HEADQUARTERS

FINLAND

JAPAN

SWEDEN

EUROPE—
HEADQUARTERS

FRANCE

THE NETHERLANDS

SWITZERLAND

AUSTRIA

GERMANY

NORWAY

UNITED KINGDOM

DENMARK

ITALY

SPAIN

2025永久免费梯子

Incyte is a global biopharmaceutical company founded on the premise that investment in strong science and the relentless pursuit of R&D excellence can translate into new solutions that can positively affect patients’ lives.

Data Provided by Refinitiv. Minimum 15 minutes delayed.

2025永久免费梯子

Upcoming

Monday August 3, 2025 at 8:00 AM EDT
Monjuvi (tafasitamab-cxix) FDA approval

Tuesday August 4, 2025 at 8:00 AM EDT
Q2 2025 Incyte Corporation Earnings Conference Call

2025永久免费梯子

View All Events

手机网络加速器免费

Monday April 6, 2025 at 8:00 AM EDT
江苏一网吧为吸引学生上网安装翻墙软件被查处_央广网 - cnr.cn:2021-12-9 · 网络安监员反电信诈骗:3年几乎没睡过几次好觉,数万元被骗、假冒淘宝客服、接警地浙江湖州、受害人是新手卖家，几条线索摆在眼前。诈骗过程很 ...

View All Events

Press Releases

网络加速器

FDA Approves Monjuvi® (tafasitamab-cxix) in Combination With Lenalidomide for the Treatment of Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)

sub免费网络加速器

Incyte Announces REACH3 Trial of Ruxolitinib (Jakafi®) in Patients with Chronic Graft-Versus-Host Disease Met Primary and Both Key Secondary Endpoints

July 16, 2025

Incyte to Report Second Quarter Financial Results

View All Releases

2025永久免费梯子

Michael Booth D.Phil
Division VP, Investor Relations & Corporate Responsibility
Phone: 302.498.5914
mbooth@incyte.com

Lauren Ayala, MBA
Senior Director, Investor Relations & Corporate Responsibility
Phone: 302.498.6141
layala@incyte.com

Christine Chiou
Senior Director, Investor Relations
Phone: 302.274.4773
cchiou@incyte.com

Annual Reports

Quarterly Reports

2025永久免费梯子

All Press Releases

All Events

All SEC Filings

2025永久免费梯子

2025永久免费梯子

2025永久免费梯子

2025永久免费梯子

Upcoming

2025永久免费梯子

手机网络加速器免费

手机网络加速器免费

Press Releases

FRONT >> News > View All

2025永久免费梯子

04. Sidebar Quicklinks

2025永久免费梯子